Lipopolysaccharide reverses adrenocorticotrophic hormone-induced hypertension in the rat

Hypertens Res. 2003 May;26(5):427-32. doi: 10.1291/hypres.26.427.

Abstract

Lipopolysaccharide (LPS) was used to stimulate nitric oxide (NO) release and investigate the effect of endogenous NO on adrenocorticotrophic hormone (ACTH)-induced hypertension in rats. After preliminary studies to determine the appropriate dose of LPS, 40 male Sprague-Dawley rats were treated with ACTH (200 microg/kg/day, s.c.) or saline (sham) for 8 days and then given a single dose of LPS (10 mg/kg, i.p.) or saline. ACTH treatment was continued for a further 5 days. Systolic blood pressure (SBP) was measured daily using the tail cuff method. Results were expressed as the mean +/- SEM. ACTH treatment significantly increased SBP (from 105 +/- 3 to 129 +/- 4 mmHg; p<0.05), whereas saline had no effect on SBP. The ACTH-induced increase in SBP was reversed by LPS injection (from 125 +/- 6 to 102 +/- 7 mmHg; p<0.05). SBP was also decreased in sham + LPS-treated rats compared with that of sham + saline-treated rats (p<0.05), but the SBP change in response to LPS was greater in ACTH-treated than in sham-treated rats (-23 vs. -8 mmHg; p<0.05). These data are compatible with the notion that reduced NO availability plays a role in ACTH-induced hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenocorticotropic Hormone / pharmacology*
  • Animals
  • Blood Pressure / drug effects
  • Body Weight / drug effects
  • Hypertension / chemically induced
  • Hypertension / drug therapy*
  • Hypertension / metabolism*
  • Lipopolysaccharides / pharmacology*
  • Male
  • Nitric Oxide / metabolism*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Lipopolysaccharides
  • Nitric Oxide
  • Adrenocorticotropic Hormone